Elly Kourany-Lefoll

Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

Eliézer K. N’Goran, Maurice R. Odiere, Ronald Assandé Aka et al. · The Lancet Infectious Diseases · 2023 · 33 citations

Malaria, Côte D'ivoire, Pediatrics +5

Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies

Wilhelmina Bagchus, Deon Bezuidenhout, Eleanor Harrison‐Moench et al. · Clinical and Translational Science · 2018 · 27 citations · Full text

Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study

Muhidin K. Mahende, Eric Huber, Elly Kourany-Lefoll et al. · PLoS neglected tropical diseases · 2021 · 23 citations · Full text

Product development programs for neglected tropical diseases: A crucial role for expert meetings

L. Hussaarts, Kim van der Weijde, Pierre Dome et al. · PLoS neglected tropical diseases · 2017 · 10 citations · Full text

Disease Management, Global Health, Malaria +9

Comparison of POC-CCA with Kato-Katz in Diagnosing Schistosoma mansoni Infection in a Pediatric L-Praziquantel Clinical Trial

Xiaoyan Yin, Eliézer K. N’Goran, Mamadou Ouattara et al. · Frontiers in Tropical Diseases · 2021 · 10 citations · Full text